BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2553509)

  • 1. [Lowering of the glycemic threshold in pituitary and adrenal response to hyperglycemia in insulinoma].
    Grimaldi A; Bosquet F; Sachon C; Davidoff P; Landault C; Zoghbi F; Duet M
    Diabete Metab; 1989; 15(4):209. PubMed ID: 2553509
    [No Abstract]   [Full Text] [Related]  

  • 2. Pre- and postoperative glucose levels for eliciting hypoglycaemic responses in a patient with insulinoma.
    Vea H; Jorde R; Sager G; Vaaler S; Sundsfjord J; Revhaug A
    Diabet Med; 1992 Dec; 9(10):950-3. PubMed ID: 1478043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for reversibility of defective counterregulation in a patient with insulinoma.
    Maran A; Taylor J; Macdonald IA; Amiel SA
    Diabet Med; 1992 Oct; 9(8):765-8. PubMed ID: 1395473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on pituitary function in patients with B-cell adenoma.
    Zaccaria M; Giordano G; Vettor R; Ragazzi E; Boscaro M; Federspil G; Scandellari C
    Horm Metab Res; 1983 Nov; 15(11):562-3. PubMed ID: 6317536
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of association between blood pressure and insulin in patients with insulinoma.
    Tsutsu N; Nunoi K; Kodama T; Nomiyama R; Iwase M; Fujishima M
    J Hypertens; 1990 May; 8(5):479-82. PubMed ID: 2163424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of the glucokinase-glucose sensor in pancreatic islets of insulinoma-bearing rats following tumor removal.
    Bedoya FJ; Appel MC; Goberna R; Matschinsky FM
    Adv Exp Med Biol; 1986; 211():447-57. PubMed ID: 3037862
    [No Abstract]   [Full Text] [Related]  

  • 7. Qualitative abnormality of insulin secretion in a case with insulinoma.
    Harano Y; Kohama M; Araki N; Sakamoto A; Hoshi M
    Endocrinol Jpn; 1975 Apr; 22(2):175-80. PubMed ID: 168060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects and secretory properties of a radiation-induced transplantable rat insulinoma.
    Flatt PR; Tan KS; Swanston-Flatt SK; Webster JD; Marks V
    Comp Biochem Physiol A Comp Physiol; 1987; 87(1):175-81. PubMed ID: 2886253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of counterregulatory hormonal responses in diabetic man by a fall in glucose concentration.
    DeFronzo RA; Hendler R; Christensen N
    Diabetes; 1980 Feb; 29(2):125-31. PubMed ID: 6986297
    [No Abstract]   [Full Text] [Related]  

  • 10. Return of beta-adrenergic sensitivity in a patient with insulinoma after removal of the tumour.
    Vea H; Trovik TS; Sager G; Birkeland K; Revhaug A; Sundsfjord J; Jorde R
    Diabet Med; 1997 Nov; 14(11):979-84. PubMed ID: 9400924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bioartificial pancreas prevents chronic complications of diabetes in rats.
    Altman JJ; McMillan P; Callard P; Galletti PM
    ASAIO Trans; 1986; 32(1):145-7. PubMed ID: 3022777
    [No Abstract]   [Full Text] [Related]  

  • 12. Defective regulation of insulin secretion in diabetes and insulinoma.
    Flatt PR
    Biochem Soc Trans; 1990 Feb; 18(1):124-7. PubMed ID: 2158914
    [No Abstract]   [Full Text] [Related]  

  • 13. Metastatic insulinoma with long survival and glucagonoma syndrome.
    D'Arcangues CM; Awoke S; Lawrence GD
    Ann Intern Med; 1984 Feb; 100(2):233-5. PubMed ID: 6318634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin.
    Ellison EC; O'Dorisio TM; Benson GD
    Am J Surg; 1986 Jun; 151(6):668-75. PubMed ID: 2872829
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe hyperglycemia: effects of rehydration on endocrine derangements and blood glucose concentration.
    Waldhäusl W; Kleinberger G; Korn A; Dudczak R; Bratusch-Marrain P; Nowotny P
    Diabetes; 1979 Jun; 28(6):577-84. PubMed ID: 109338
    [No Abstract]   [Full Text] [Related]  

  • 16. Patients with insulinoma show insulin resistance in the absence of arterial hypertension.
    Pontiroli AE; Alberetto M; Pozza G
    Diabetologia; 1992 Mar; 35(3):294-5. PubMed ID: 1563588
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulinoma: clinical manifestations, diagnosis and treatment. The significance of the prolonged fasting test and of the fasting blood glucose-insulin relationship.
    Johansen K
    J Endocrinol Invest; 1979; 2(3):285-90. PubMed ID: 231064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a transplantable insulinoma upon regulatory peptide concentrations in the gastrointestinal tract of the rat.
    Conlon JM; Deacon CF; Bailey CJ; Flatt PR
    Diabetologia; 1986 May; 29(5):334-8. PubMed ID: 3013708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulinoma-associated transient hypothalamus-pituitary-adrenal axis impairment and amelioration by steroid therapy and surgical intervention: a case report.
    Chang YH; Hsieh MC; Hsin SC; Shin SJ; Lin KD
    Kaohsiung J Med Sci; 2007 Oct; 23(10):526-30. PubMed ID: 18055299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Documented hypoglycemia for 23 years in a patient with insulinoma.
    Nelson RL; Rizza RA; Service FJ
    JAMA; 1978 Oct; 240(17):1891. PubMed ID: 211277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.